A novel screening model for the molecular drug for diabetes and obesity based on tyrosine phosphatase Shp2

被引:19
作者
Bu, Yanyan [2 ,3 ]
Shi, Tao [1 ]
Meng, Minghui [2 ,3 ]
Kong, Guiping [2 ,3 ]
Tian, Yingpu [2 ,3 ]
Chen, Quancheng [1 ]
Yao, Xinsheng [1 ,4 ]
Feng, Gensheng [2 ,3 ,5 ]
Cheng, Haifeng [1 ]
Lu, Zhongxian [2 ,3 ]
机构
[1] Xiamen Univ, Nat Prod Res Ctr, Inst Biomed Res, Xiamen 361005, Fujian, Peoples R China
[2] Xiamen Univ, Xiamen City Key Lab Metab Dis, Xiamen 361005, Fujian, Peoples R China
[3] Xiamen Univ, Metab Dis Res Ctr, Inst Biomed Res, Xiamen 361005, Fujian, Peoples R China
[4] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China
[5] Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92093 USA
基金
中国国家自然科学基金;
关键词
Shp2; enhancer; Screening system; Diabetes; Oleanolic acid; OLEANOLIC ACID; MEDICINAL FOODSTUFFS; INSULIN-SECRETION; RATS; EXPRESSION; RESISTANCE; INHIBITORS; DELETION; DEATH; MICE;
D O I
10.1016/j.bmcl.2010.11.049
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tyrosine phosphatase Src-homology phosphotyrosyl phosphatase 2 (Shp2) was identified as a potential molecular target for therapeutic treatment of diabetes and obesity. However, there is still no systematic research on the enhancers for the Shp2 enzyme. The present study established a novel powerful model for the high-throughput screening of Shp2 enhancers and successfully identified a new specific Shp2 enhancer, oleanolic acid, from Chinese herbs. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:874 / 878
页数:5
相关论文
共 33 条
[1]   Early fetal death associated with compound heterozygosity for Noonan syndrome-causative PTPN11 mutations [J].
Becker, Kristin ;
Hughes, Helen ;
Howard, Karol ;
Armstrong, Maggie ;
Roberts, Devender ;
Lazda, Edgar J. ;
Short, John P. ;
Shaw, Adam ;
Patton, Michael A. ;
Tartaglia, Marco .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (11) :1249-1252
[2]   Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor [J].
Chen, Liwei ;
Sung, Shen-Shu ;
Yip, M. L. Richard ;
Lawrence, Harshani R. ;
Ren, Yuan ;
Guida, Wayne C. ;
Sebti, Said M. ;
Lawrence, Nicholas J. ;
Wu, Jie .
MOLECULAR PHARMACOLOGY, 2006, 70 (02) :562-570
[3]   The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway [J].
Dance, Marie ;
Montagner, Alexandra ;
Salles, Jean-Pierre ;
Yart, Armelle ;
Raynal, Patrick .
CELLULAR SIGNALLING, 2008, 20 (03) :453-459
[4]   Protein tyrosine phosphatases: mechanisms of catalysis and regulation [J].
Denu, JM ;
Dixon, JE .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (05) :633-641
[5]   Shp2 is dispensable in the formation and maintenance of the neuromuscular junction [J].
Dong, Xian-Ping ;
Li, Xiao-Ming ;
Gao, Tian-Ming ;
Zhang, Eric E. ;
Feng, Gen-Sheng ;
Xiong, Wen C. ;
Mei, Lin .
NEUROSIGNALS, 2006, 15 (02) :53-63
[6]   Shp2 as a therapeutic target for leptin resistance and obesity [J].
Feng, GS .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (01) :135-142
[7]  
Feng Ying-lu, 2006, Zhonghua Zhongliu Zazhi, V28, P844
[8]  
Feng Zi-ming, 2005, Yaoxue Xuebao, V40, P150
[9]   Antidiabetic and Antioxidant Effects of Oleanolic Acid from Ligustrum lucidum Ait in Alloxan-induced Diabetic Rats [J].
Gao, Dawei ;
Li, Qingwang ;
Li, Ying ;
Liu, Zhihua ;
Fan, Yusheng ;
Liu, Zhiwei ;
Zhao, Hongwei ;
Li, Jian ;
Han, Zengsheng .
PHYTOTHERAPY RESEARCH, 2009, 23 (09) :1257-1262
[10]   Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking [J].
Hellmuth, Klaus ;
Grosskopf, Stefanie ;
Lum, Ching Tung ;
Wuertele, Martin ;
Roeder, Nadine ;
von Kries, Jens Peter ;
Rosario, Marta ;
Rademann, Joerg ;
Birchmeier, Walter .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (20) :7275-7280